To this end, we present a mouse model employingthe coadministration of the aerosolized SARS-CoV-2 S protein and bacterialLPS to the lungs, producing severe pulmonary inflammation and a cytokineprofile sharing features observed during COVID-19 disease progression. This evidence concerns the gene PROS1 and COVID-19.